Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes

被引:24
|
作者
Narimatsu, S
Kobayashi, N
Masubuchi, Y
Horie, T
Kakegawa, T
Kobayashi, H
Hardwick, JP
Gonzalez, FJ
Shimada, N
Ohmori, S
Kitada, M
Asaoka, K
Kataoka, H
Yamamoto, S
Satoh, T
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Lab Hlth Chem, Okayama 700, Japan
[2] Chiba Univ, Fac Pharmaceut Sci, Lab Biopharmaceut, Chiba 260, Japan
[3] Chiba Univ, Fac Pharmaceut Sci, Fac Med, Biochem Lab, Chiba 260, Japan
[4] NCI, Mol Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA
[5] Daiichi Kagaku Co, Technores Ctr, Ibaraki, Osaka, Japan
[6] Chiba Univ, Fac Med, Chiba Univ Hosp, Div Pharm, Chiba, Japan
[7] Kyoto Univ, Primate Res Inst, Div Mol Physiol, Aichi, Japan
[8] Biomed Res Inst, Chiba, Japan
关键词
CYP2D6; human liver microsomes; monkey liver microsomes; propranolol; enantioselectivity; heterologous expression system;
D O I
10.1016/S0009-2797(00)00174-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined and compared enantioselectivity in the oxidation of propranolol (PL) by liver microsomes from humans and Japanese monkeys (Macaca fuscata). PL was oxidized at the naphthalene ring to 4-hydroxypropranolol, 5-hydroxypropranolol and side chain N-desisopropylpropranolol by human liver microsomes with enantioselectivity of [R(+)> S(-)] in PL oxidation rates at substrate concentrations of 10 mu M and 1 mM. In contrast, reversed enantioselectivity [R(+)< S(-)] in PL 5-hydroxylation and N-desalkylation rates at the same substrate concentrations was observed in monkey liver microsomes, although the selectivity was the same for PL 4-hydroxylation between the two species. All oxidation reactions of the PL enantiomers in human liver microsomes showed biphasic kinetics, i.e. the reactions could be expressed as the summation of a low-K-m phase and a high-K-m phase. Inhibition studies using antibodies and characterization of CYP2D6 enzymes expressed in insect cells or human lymphoblastoid cells indicated that the enantioselectivity of PL oxidation, especially the ring 4- and 5-hydroxylations reflected the properties of CYP2D6 in human liver microsomes. In monkey liver microsomes, all of the oxidation reactions of S( -)-PL showed biphasic kinetics, whereas ring 4- and 5-hydroxylations were monophasic and side chain N-desisopropylation was biphasic for R(+)-PL. Similarly, from the results of inhibition studies using antibodies and inhibitors of cytochrome P450 (P450), it appears that the reversed selectivity [R(+)<S(-)] of PL oxidation rates is catalyzed by CYP2D enzyme(s) in monkey liver at low substrate concentrations. These results indicate that different properties of P450s: belonging to the 2D subfamily cause the reversed enantioselectivity between human and monkey liver microsomes. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:73 / 90
页数:18
相关论文
共 50 条
  • [21] Oxidation of long chain aldehydes by human cytochrome P450 enzymes
    Iradi, Jonathon B.
    Raner, Gregory M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [22] Oxidation of furan to a reactive metabolite by human cytochrome P450 enzymes
    Brus, Leah A.
    Lu, Ding
    Peterson, Lisa A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [23] Hydroxylation by the hydroperoxy-iron species in cytochrome P450 enzymes
    Chandrasena, REP
    Vatsis, KP
    Coon, MJ
    Hollenberg, PF
    Newcomb, M
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (01) : 115 - 126
  • [24] Photochemical oxidation of cytochrome P450
    Ener, Maraia E.
    Cheruzel, Lionel
    Winkler, Jay R.
    Gray, Harry B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [25] Allosteric effects of cytochrome P450 reductase on cytochrome P450 2D6
    Roberts, GCK
    Modi, S
    Gilham, DE
    Sutcliffe, MJ
    Lian, LY
    Primrose, WU
    Wolf, CR
    FASEB JOURNAL, 1997, 11 (09): : A789 - A789
  • [26] Oxidation of methoxytyramines by recombinant cytochrome P450 2D6
    Hanna, IH
    Nishimura, Y
    Miller, GP
    Rizzo, CJ
    Guengerich, FP
    FASEB JOURNAL, 2000, 14 (08): : A1335 - A1335
  • [27] Differential Cytochrome P450 2D Metabolism Alters Tafenoquine Pharmacokinetics
    Vuong, Chau
    Xie, Lisa H.
    Potter, Brittney M. J.
    Zhang, Jing
    Zhang, Ping
    Duan, Dehui
    Nolan, Christina K.
    Sciotti, Richard J.
    Zottig, Victor E.
    Nanayakkara, N. P. Dhammika
    Tekwani, Babu L.
    Walker, Larry A.
    Smith, Philip L.
    Paris, Robert M.
    Read, Lisa T.
    Li, Qigui
    Pybus, Brandon S.
    Sousa, Jason C.
    Reichard, Gregory A.
    Smith, Bryan
    Marcsisin, Sean R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 3864 - 3869
  • [28] Biotechnological applications of cytochrome P450 enzymes
    Munro, A.
    McLean, K.
    Belcher, J.
    Matthews, S.
    Girvan, H.
    Tee, K.
    Poddar, H.
    Andrews, A.
    Leys, D.
    Hans, M.
    van den Berg, M.
    Jeffreys, L.
    FEBS OPEN BIO, 2018, 8 : 21 - 21
  • [29] Use of bioconjugation with cytochrome P450 enzymes
    Ducharme, Julie
    Auclair, Karine
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2018, 1866 (01): : 32 - 51
  • [30] Cytochrome P450 enzymes in the fungal kingdom
    Cresnar, B.
    Petric, S.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2011, 1814 (01): : 29 - 35